Company intelligence / Profile preview

FREmedica Technologies

Victoria, British Columbia, Canada

Ownership: Private
Development stage: Other

Overview

NIKKI is a wearable device commercially available since 2024, with reported improvements in wellness and quality of life for individuals with chronic health conditions; a recent beta test found significant benefits for 73% of users in mood, energy, and wellness[2][1].

Therapeutic areas: ImmunologyEndocrinologyRheumatologyInfectious DiseasesNeurologyPsychiatry
Modalities: DeviceNon-pharmacological therapy
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on FREmedica Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on FREmedica Technologies.

Explore the full profile